2026-05-15T14:10:43Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/jgro.000051 2018-06-20 PTZ.JGRO:VOL4

Bacterial Vaginosis: Risk of Adverse Pregnancy Outcome Arif Faruqui<p>The reproductive health of a woman is vital not only for her general health, but also for that of her</p><p>partner and child. Bacterial infections can affect pregnant women from implantation of the fertilized</p><p>ovum through the time of delivery and peripartum period. They may also affect the fetus and newborn.</p><p>Symptomatic pregnant women with confi rmed bacterial vaginosis should be treated. Treatment of</p><p>pregnant women with asymptomatic bacterial vaginosis is controversial. Guidelines from the Centers for</p><p>Disease Control and Prevention (CDC) recommend treating asymptomatic high-risk pregnant women with</p><p>bacterial vaginosis. Antibiotic treatment can eradicate bacterial vaginosis in pregnancy but overall risk of</p><p>preterm birth (PTB) is not signifi cantly reduced. Present antibiotic therapy (metronidazole and</p><p>clindamycin), both oral and vaginal, do not reduce the risk of PTB. Probiotics have capability to increase</p><p>vaginal lactobacilli, restore the vaginal microbiota to normal and hence helps to cure bacterial vaginosis.</p><p>Therefore, Probiotics should be considered as part of the prevention and as an adjunct to antimicrobial</p><p>treatment approach for BV.</p> Journal of Gynecological Research and Obstetrics - Peertechz Publications 2018-06-20 Review Article https://doi.org/10.17352/jgro.000051 en Copyright © Arif Faruqui et al.